| Literature DB >> 29657450 |
Sandip P Tarpada1, Matthew T Morris1, Jayson Lian1, Sina Rashidi1.
Abstract
Despite advances elucidating the causes of lateral and medial epicondylitis, the standard of care remains conservative management with NSAIDs, physical therapy, bracing, and rest. Scar tissue formation provoked by conservative management creates a tendon lacking the biomechanical properties and mechanical strength of normal tendon. The following review analyzes novel therapies to regenerate tendon and regain function in patients with epicondylitis. These treatments include PRP injection, BMAC, collagen-producing cell injection, and stem cell treatments. While these treatments are in early stages of investigation, they may warrant further consideration based on prospects of pain alleviation, function enhancement, and improved healing.Entities:
Keywords: Lateral/medial epicondylitis; Stem cell therapy; Tendonopathy; Tenocyte therapy
Year: 2018 PMID: 29657450 PMCID: PMC5895908 DOI: 10.1016/j.jor.2018.01.040
Source DB: PubMed Journal: J Orthop ISSN: 0972-978X